Synexus Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Chorley United Kingdom (1992)
Status: Acquired by PPD (2016) → now Thermo Fisher Scientific (2021)

Organization Overview

First Clinical Trial
2012
NCT01631227
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Desert Clinical Research | Synexus Manchester Clinical Research Centre | Synexus Merseyside Clinical Research Centre | Synexus Midlands Clinical Research Centre | Synexus Scotland Clinical Research Centre